Blood test could predict brain tumor return
NCT ID NCT07282470
Summary
This study aims to develop better ways to predict whether meningioma brain tumors will return after treatment. Researchers will analyze tumor tissue and blood samples from 210 patients to identify molecular markers that indicate recurrence risk. The goal is to create a blood test that can help doctors personalize monitoring and treatment plans for patients with these common brain tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITINGMilan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.